Premier Biomedical, Inc.
BIEI · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $587 | $714 | $1,099 | $879 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $703 | $608 | $0 | $568 |
| Enterprise Value | $1,290 | $1,322 | $1,099 | $1,447 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$12 | -$11 | -$18 | -$11 |
| % Margin | – | – | – | – |
| Net Income | -$12 | -$18 | -$53 | -$11 |
| % Margin | – | – | – | – |
| EPS Diluted | 0 | 0 | 0 | 0 |
| % Growth | – | – | – | – |
| Operating Cash Flow | – | – | – | – |
| Capital Expenditures | – | – | – | – |
| Free Cash Flow | – | – | – | – |